Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00369746 · ClinicalTrials.gov registry record
STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 674
- Enrollment target
NCT00369746 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 674 participants.
The verdict
NCT00369746 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 674 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is also accompanied by improvement in the alcohol use disorder.
Interventions
- DRUG citalopram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 674 participants |
| Start Date | 2006-09 |
| Est. Completion | 2009-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00369746
The ClinicalTrials.gov registry entry for NCT00369746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 674 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which citalopram is the first listed.
NCT00369746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00369746 about?
NCT00369746 is a clinical study titled "STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse". The purpose of this study is to determine if having an alcohol use disorder affects recovery from depression, and also whether recovery from depression in patients who have alcohol use disorders is also accompanied by improvement in the alcohol use disorder.
What is the current status of trial NCT00369746?
This trial is currently completed. The enrollment target is 674 participants. The study started on 2006-09. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00369746?
The interventions under investigation include: citalopram (DRUG).
Who is sponsoring clinical trial NCT00369746?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.